Antibiotic susceptibilities of Helicobacter pylori strains isolated in the Province of Alberta

Canadian Journal of Gastroenterology

Volumn 12, Issue 4, 1998, Pages 295-298

  Taylor, Diane E ^a   Jiang, Qin ^a   Fedorak, Richard N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antibiotic resistance; Clarithromycin; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; ERYTHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; DILUTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; STOMACH BIOPSY;

EID: 0031865684     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/672746     Document Type: Article

References (27)

1. Veldhuyzen van Zanten SJO, Sherman PM, Hunt RH. Helicobacter pylori: new developments and treatments. Can Med Assoc J 1997;156:1565-74.
2. NIH Consensus Conference Development Panel. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. Hunt R, Thomson ABR. Canadian Helicobacter pylori Consensus Conference. Can J Gastroenterol 1998;12:31-41.
4. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-6.
5. Taylor DE, Hargreaves JA, Ng L-K, Sherbaniuk RW, Jewell LD. Isolation and characterization of Campylobacter pyloridis from gastric biopsies. Am J Clin Pathol 1987;87:49-54.
6. Wang Y, Roos KP, Taylor DE. Transformation of Helicobacter pylori by chromosomal metronidazole resistance and by a plasmid with a selectable chloramphenicol resistance marker. J Gen Microbiol 1993;139:2485-93.
7. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of 23S rRNA genes from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997;41:2621-8.
8. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications, 1994.
9. Midolo PD, Korman MG, Turnidge JD, Lambert JR. Helicobacter pylori resistance to tetracycline. Lancet 1996;347:1194-5. (Lett)
10. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997;35:1842-6.
11. Goddard AF, Logan RPH. Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemother 1996;37:639-43.
12. Loo VG, Fallone CA, De Souza E, Lavallée J, Barkun AN. In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole. J Antimicrob Chemother 1997;40:881-3.
13. Best LM, Haldane DJM, Bezanson GS, Veldhuyzen van Zanten SJO. Helicobacter pylori: Primary susceptibility to clarithromycin in vitro in Nova Scotia. Clin Gastroenterol 1997;11:298-300.
14. Versalovic J, Shortridge D, Kibler K, et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 1996;40:477-80.
15. Glupczynski Y, Burette A, De Koster A, et al. Epidemiological factors associated with metronidazole resistance in Helicobacter pylori. Lancet 1990;i:976-7.
16. Fedorak R, Archambault A, Flamm R, Osato M, Stamler D. Antimicrobial susceptibility of H. pylori in Canada to three key antibiotics: metronidazole, clarithromycin and amoxicillin. Gastroenterology 1997;112:A115.
17. Best LM, Haldane DJM, Veldhuyzen van Zanten SJO. Susceptibility of H. pylori in Canada to clarithromycin and metronidazole. Gut 1996;39(Suppl 2):A13. (Abst)
18. Vasquez A, Valdez Y, Gilman RH, et al. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. J Clin Microbiol 1996;34:1232-4.
19. Wurzer H, Rodrigo L, Stamler D, et al. Short course therapy with amoxicillin-clarithromycin triple for 10 days (ACT-10) eradicates H. pylori and heals duodenal ulcer. Aliment Pharmacol Ther 1998;11:943-52.
20. Taylor NS, Fox JG, Akopyants NS, et al. Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. J Clin Microbiol 1995;33:918-23.
21. Henriksen TH, Brorson Ö, Schöyen R, Thoresen T, Lia A. A simple method for determining metronidazole resistance of Helicobacter pylori. J Clin Microbiol 1997;35:1424-6.
22. van Zwet AA, Thijs JC, de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother 1995;39:250-2.
23. Debets-Ossenkopp YJ, Sparrius M, Kusters JG, Kolkman JJ, Vandenbroucke-Grauls CMJE. Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori. FEMS Microbiol Lett 1996;142:37-42.
24. Becx MCMJ, Jansen AJHM, Clasener HAL, de Koning RW, et al. Metronidazole-resistant Helicobacter pylori. Lancet 1990;i:539-40.
25. Sanford JP, Gilbert DN, Sande MA. Guide to Antimicrobial Therapy, 26th edn. Dallas: Antimicrobial Therapy, Inc, 1996:55.
26. Glupczynski Y, Labbé M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J Clin Microbiol 1991;29:2072-5.
27. Hachem CY, Clarridge JE, Reddy R, et al. Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996;24:37-41.